Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 10Condylomata Acuminata 3Head and Neck Neoplasms 2Colorectal Neoplasms 2Warts 1Virus Diseases 1Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Sexually Transmitted Diseases 1Radiodermatitis 1Papillomavirus Infections 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Keratosis, Seborrheic 1Hemangioma, Cavernous 1Hemangioma 1Head and Neck Cancer Patients Treated With Radiotherapy 1Exanthema 1Dermatitis, Contact 1Carcinoma, Basal Cell 1Carcinoma 1

Interventions

Cryotherapy 7resiquimod 6Cantharidin 4Cholecalciferol 3PRA1 protein, Candida albicans 2N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Measles-Mumps-Rubella Vaccine 22-Propanol 2plerixafor 1methyl 5-aminolevulinate 1lactic acid, salicylic acid drug combination 1green tea extract polyphenone E 1gluconic acid 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1VP-102 1Tuberculin 1Trichloroacetic Acid 1Sugars 1Starch 1Photochemotherapy 1Nitric Oxide 1Mass Screening 1Maltose 1Lasers, Solid-State 1Lasers 1Interferon-alpha 1Imiquimod 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Warts × Gels × Clear all
NCT02748902 2017-07-17

Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.

TCR Medical Corporation

Phase 1 Completed
16 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡